Abbott Laboratories Share Price London S.E.
Stocks
ABT
US0028241000
Medical Equipment, Supplies & Distribution
|
Delayed
London S.E.
07:00:22 15/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 102.90 USD | -3.03% |
|
-2.75% | -18.21% |
| 15/09 | Abbott Announces First Canadian Use of Volt Pulsed Field Ablation System to Treat Atrial Fibrillation | CI |
| 14/09 | Abbott Laboratories to Pay $385 Million to Settle Infant Formula Allegations | MT |
| Market Cap | 18TCr 15TCr 15TCr 13TCr 25TCr 16,99200Cr 25TCr 1,73200Cr 67TCr 8,61800Cr 67TCr 65TCr 27,47100Cr | P/E 2026 * |
29x | P/E 2027 * | 22.5x |
|---|---|---|---|---|---|
| Enterprise Value | 20TCr 17TCr 16TCr 15TCr 28TCr 19,28800Cr 28TCr 1,96600Cr 76TCr 9,78300Cr 76TCr 74TCr 31,18300Cr | EV / Sales 2026 * |
4x | EV / Sales 2027 * | 3.63x |
| Free-Float |
86.16% | Yield 2026 * |
2.51% | Yield 2027 * | 2.68% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| ABT | Delayed | |
CBOE
| ABT | Real-time | |
|
London S.E.
| ABT | Delayed | |
|
Xetra
| ABL | Delayed | |
|
Tradegate
| ABL | Real-time | |
|
Boerse Muenchen
| ABL | Real-time | |
|
Mexican S.E.
| ABT * | End-of-day quote | |
|
CBOE
| ABT | Real-time | |
|
Kazakhstan S.E.
| ABT_KZ | End-of-day quote | |
|
Swiss Exchange
| ABT | Delayed | |
|
Lima
| ABTUS | End-of-day quote | |
|
Wiener Boerse
| ABT | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Santiago S.E.
| ABT | End-of-day quote | |
|
Santiago S.E.
| ABTCL | End-of-day quote | |
|
Deutsche Boerse AG
| ABL | Delayed | |
|
Börse Stuttgart
| ABL | Delayed | |
|
Borsa Italiana
| 1ABT | End-of-day quote |
Last Transcript: Abbott Laboratories
| 1 day | -3.03% | ||
| 1 week | -2.75% | ||
| Current month | -6.95% | ||
| 1 month | -7.62% | ||
| 3 months | +14.82% | ||
| 6 months | -5.85% | ||
| Current year | -18.21% |
| 1 week | 100.4 |  | 105.14 |
| 1 month | 100.4 | | 118 |
| Current year | 82.05 | | 129.37 |
| 1 year | 82.05 | | 137.44 |
| 3 years | 82.05 | | 141.41 |
| 5 years | 82.05 | | 142.15 |
| 10 years | 38.23 | | 142.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 31/03/2020 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 01/09/2023 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 09/12/2011 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 09/12/2011 |
Daniel Starks
BRD | Director/Board Member | 71 | 16/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.03% | -2.75% | - | - | 18TCr | |
| +0.32% | -2.73% | -22.90% | +0.61% | 18TCr | |
| -1.23% | +0.77% | -1.69% | +13.24% | 12TCr | |
| -1.48% | -1.49% | +9.83% | +78.64% | 6.08TCr | |
| -2.19% | +1.14% | -2.34% | -31.05% | 4.95TCr | |
| +1.18% | -2.07% | +6.21% | +40.76% | 4.83TCr | |
| +1.03% | +4.12% | +14.10% | -9.35% | 3.3TCr | |
| +2.74% | -3.11% | - | - | 2.89TCr | |
| -0.82% | +7.44% | +40.12% | -8.16% | 2.55TCr | |
| +0.26% | +4.35% | +9.55% | -21.04% | 2.18TCr | |
| Average | -0.01% | +0.55% | +6.61% | +7.96% | 6.26TCr | |
| Weighted average by Cap. | -0.40% | -0.55% | -3.33% | +11.06% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.02TCr 4.35TCr 4.11TCr 3.73TCr 7TCr 4,81600Cr 7.04TCr 49TCr 19TCr 2,44300Cr 19TCr 18TCr 7,78600Cr | 5.45TCr 4.73TCr 4.47TCr 4.05TCr 7.6TCr 5,23100Cr 7.64TCr 53TCr 21TCr 2,65300Cr 20TCr 20TCr 8,45700Cr |
| Net income | 630.32Cr 546.23Cr 516.28Cr 468.7Cr 878.45Cr 60TCr 883.7Cr 6.16TCr 2.38TCr 31TCr 2.37TCr 2.32TCr 98TCr | 797.76Cr 691.34Cr 653.43Cr 593.21Cr 1.11TCr 77TCr 1.12TCr 7.8TCr 3.01TCr 39TCr 3TCr 2.93TCr 1,23700Cr |
| Net Debt | 2.39TCr 2.07TCr 1.96TCr 1.78TCr 3.34TCr 2,29700Cr 3.36TCr 23TCr 9.05TCr 1,16500Cr 8.99TCr 8.79TCr 3,71300Cr | 2.1TCr 1.82TCr 1.72TCr 1.56TCr 2.92TCr 2,01000Cr 2.94TCr 20TCr 7.92TCr 1,02000Cr 7.87TCr 7.7TCr 3,25000Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | $103.17 | +0.69% | 2,600 |
| 15/26/15 | $102.46 | -0.43% | 7,966 |
| 14/26/14 | $102.90 | +0.74% | 8,116 |
| 11/26/11 | $102.14 | -1.72% | 25,253 |
| 10/26/10 | $103.93 | -1.78% | 2,483 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
